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Chapter 1
Capstone Report Introduction
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Introduction
The United States health care system is currently experiencing an increase in demand for
services due to an aging population. Currently over 46 million Americans are affected by
arthritic conditions with an estimated increase to 67 million by 2030 (Centers for Disease
Control and Prevention, 2009). Rheumatology, an Internal Medicine sub-specialty, treats those
patients with arthritic conditions as well as other autoimmune and inflammatory conditions such
as systemic lupus erythematosus, gout, and fibromyalgia (American College of Rheumatology,
2012). A shortage of 2,609 rheumatologists is projected by 2025, adding additional stress to an
already burdened clinical area (Deal et al., 2007). This means patients can face substantial wait
times when requesting consultation with a rheumatology provider. This is problematic since
early pharmacological intervention is the standard of care for many rheumatic diseases including
initiation of disease-modifying antirheumatic drugs (DMARDs) for patients with rheumatoid
arthritis (RA) within the first six months of disease activity (West & West, 2014). In order to
address the shortage of providers and the increase in demand for services, some rheumatology
clinics have implemented triage systems to prioritize patients to ensure acutely ill patients are
seen within an appropriate time frame (Graydon & Thompson, 2008; Sathi, Whitehead, &
Grennan, 2003). Additionally, primary care providers (PCPs) play an integral part in early
recognition and referral for those patients presenting with inflammatory arthritis.
Communication of accurate and detailed referral information can avoid delays in care and
improve patient outcomes.
This capstone project will present three manuscripts that explore the referral process from
primary to specialty care and strategies to reduce wait times. The first manuscript is a literature
review that presents information surrounding current referral processes. Various strategies that
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have been developed to address poor communication between providers, a lack of guidelines,
and disagreement on urgency are explored (Chew-Graham, Slade, Montana, Stewart, & Gask,
2007; De Coster, Fitzgerald, & Cepoiu, 2008; Speed & Crisp, 2005). The second manuscript
presents current evidence-based practice guidelines on the identification and management of RA
in primary care. It emphasizes the importance of a timely referral to a rheumatology provider and
communication of supporting history, physical, laboratory studies and radiographs. PCP
involvement is integral in decreasing wait times and assuring patients receive timely access to
specialty care. Finally, the third manuscript evaluates a rheumatology patient prioritization triage
system currently being used in a large rheumatology clinic in central Kentucky to determine its
accuracy in identifying acutely ill patients. The combined information presented in these
manuscripts help support recommendations for improving the referral process between primary
and specialty providers to ensure that patients receive necessary care delivered in a timely
manner to optimize patient experience and outcomes. Suggestions for practice and future
research will also be identified and discussed.
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Chapter 2
Manuscript #1:
Literature Review on Specialty Referrals and Triage Systems
Katharine Layton, BSN, RN
Elizabeth Tovar, PhD, APRN
Elizabeth Salt, PhD, APRN
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Abstract
The increasing prevalence of rheumatic disease and the relatively low number of available
specialists have resulted in significant wait times for appointments. Various strategies are used to
ensure acutely ill patients are seen in a timely manner. The objective of this literature review is to
describe the current evidence related to referral processes, tools, and triage systems used by
specialty practices when prioritizing patient referrals. The findings from this review suggest
there is a knowledge deficit related to criteria for appropriate patient referrals and there is no
standardized information required with referrals. However, several tools and systems have been
evaluated in order to improve patient wait times and to ensure urgent patients are assessed and
treated in a timely manner. The literature supports the development of referral guidelines for
musculoskeletal diseases and preappointment triage of new patients by specialty providers, in
order to identify inappropriate referrals and more promptly treat acutely ill patients.
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Background
Rheumatology is an internal medicine sub-specialty that focuses on the treatment of
rheumatic conditions such as fibromyalgia, gout, and systemic lupus erythematosus (American
College of Rheumatology, 2012; Table 1). Many rheumatologic conditions are referenced as
arthritic conditions, and are the most common cause of disability in the U.S. (Klippel, Stone, &
White, 2008). They affect over 46 million adults and are costly, with estimated direct and
indirect costs of 128 billion U.S. dollars (Centers for Disease Control and Prevention, 2009;
Helmick et al., 2008; Klippel et al., 2008). Of critical importance is the exponential growth of
these conditions in the U.S. population with the rates reported in 2009 13 times larger than those
in 1999 (CDC, 2009). Because of an aging population, the prevalence of arthritic conditions is
expected to increase to 67 million by 2030. This increase will affect already burdened clinical
areas treating rheumatic diseases (CDC, 2009).
Table 1. Prevalence and Description of Common Rheumatic Conditions

Rheumatic Condition

Prevalence

Osteoarthritis

46.4 million

Fibromyalgia

5 million

Rheumatoid Arthritis

1.3 million

Systemic Lupus
Erythematosus

161,000-322,000

(Centers for Disease Control and Prevention, 2009; Helmick et al., 2008)
At present, there are only 4,946 rheumatologists in the U.S. and most patients have to
wait an average of 41 days for an appointment with a rheumatology provider (Kirwan, 1997). A
shortage of 2,609 rheumatologists is projected by 2025 (Deal et al., 2007). Wait times for
appointments will increase and result in delayed care, which is important because timely
6

treatment including earlier specialty consultation significantly improves health outcomes
(Möttönen et al., 2002; Pincus, Gibofsky, & Weinblatt, 2002; Yelin, Such, Criswell, & Epstein,
1998). For example, disease-modifying antirheumatic drugs (DMARDs) are ideally initiated
within the first six months of disease onset for a patient with rheumatoid arthritis which is also
referred to as RA (Oliver & St. Clair, 2008). Delayed treatment of the persistent inflammation
from RA can lead to irreversible joint damage and disability, which contributes to the morbidity
and mortality for this population (Oliver & St. Clair, 2008).
Because of increasing numbers of patients requiring treatment and the shortage of
specialized health care providers, various strategies (e.g., referral guidelines, patient
prioritization systems, pre-appointment management) are used to screen patient information and
prioritize the order in which they receive an appointment (Graydon & Thompson, 2008;
Harrington & Walsh, 2001; Pincus et al., 2002). These systems are implemented to avoid
delayed care for those in need, but to date, a standard of care for the management of
rheumatology patient referrals has not been established. Therefore, the purpose of this literature
review is to examine the evidence related to referral processes, tools, and triage systems used by
primary and specialty care providers. Rheumatology is not the only area where an inequity
between patients requiring care and available providers leads to extended wait times. In order to
explore all possible mechanisms used to address the lack of providers available to offer subspecialty care, referral processes used by other sub-specialty areas were included in this literature
review.
Methods
A review of the literature was conducted in order to identify the published data on
specialty referrals systems. The databases PubMed, CINAHL, and PsychInfo were searched with
no date limitation. Along with these searches, a manual review of reference lists for the relevant
7

published articles was completed. The search terms referral process, referral system, specialty
referrals, wait times, waiting times, and patient prioritization were used. Those articles
published in the English language involving the study of human participants 18 years of age or
older were included in this review. Selected articles focused on the referral process between
primary and specialty providers and waiting times that patients experienced between the referral
and appointment. Articles that addressed waiting times in emergency departments as well as
waiting times in the office were excluded because they do not address scheduled waiting times
for a consultation with a specialty provider. Article titles and abstracts were sorted and literature
relevant to the topic of referrals from primary care to specialty care, without regard to disease,
including tools and triage systems, were evaluated. These searches yielded 472 articles; of the 24
that met inclusion criteria, five were classified as evidence highlighting the need to improve the
referral process due to a shortage of specialists and improved outcomes for patients under
specialty care, five described current referral processes or guidelines, ten described interventions
developed and evaluated to improve the referral process, and four described tools that have been
developed but not formally evaluated (See Figure 1).
Figure 1. Representation of Article Selection.
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Results
Evidence Supporting the Need to Improve the Referral Process
The literature suggests that patients who receive specialty care receive evidence-based
treatments earlier in the disease process (Möttönen et al., 2002; Yelin et al., 1998) yet it also
suggests there is an inadequate supply of specialty providers, including rheumatologists
(Helmick et al., 2008). Therefore, improvements to the referral process are needed in order to
ensure that patients receive timely care. The increasing prevalence of rheumatic conditions and
the need for additional specialists provides evidence to support the future supply and demand
mismatch for rheumatology services (Helmick et al., 2008; Kirwan, 1997). The literature
indicates that there are current substantial wait times of 34-48 days for specialty care and that
this situation will continue to get worse in the immediate future (Centers for Disease Control and
Prevention, 2009; Deal et al., 2007; Hootman & Helmick, 2006). Hootman and Helmick (2006)
concluded that by 2030 there will be an increase of 20 million adults with arthritis. Deal et al.
(2007) conducted a survey to estimate the future number of rheumatology providers. When the
gender of providers is analyzed, data suggest that women see fewer patients; this finding is
9

significant since the number of women in the rheumatology workforce has risen significantly.
They also concluded that a 30% increase in fellowship positions every five years would be
necessary in order to keep up with the demand for rheumatology services (Deal et al., 2007). It
has been shown that patients are more likely to attend appointments when they experience
waiting times of two weeks or less compared to those waiting one to three months. This evidence
further supports the benefits of reducing waiting times for specialty consultations (Hicks &
Hickman, 1994).
Current literature on health outcomes for patients receiving care from specialists versus
PCPs supports the need for referrals. Two articles provide support for the importance of patients
receiving a timely consultation with a specialist in order to initiate medications earlier and
achieve improved symptom control. McAlister and colleagues (2007) conducted a study of
patients and found that those under specialty care were more likely to receive recommended
pharmacological interventions. Yelin and colleagues (1998) conducted a longitudinal study (N=
1,025) comparing those receiving care in a rheumatology specialty versus primary care, and
found that measures of joint pain (p=.01) and swelling (p=.22), morning stiffness, global pain
(p=.57), functional status, and global improvement were better for the rheumatology group, but
the authors were unable to find a statistically significant difference.

Current Referral Processes or Guidelines
A number of researchers have evaluated the referral process between primary and
specialty care. Their findings indicate that there is a lack of understanding and agreement
between the referrers and the specialists in relation to referral processes (De Coster et al.,
2008)Chew-Graham, Slade, Montana, Stewart, & Gask, 2007). Studies, conducted in several
countries using different health care systems across a variety of sub-specialties, all outline the
10

lack of agreement between PCPs and specialists (De Coster, Fitzgerald, & Cepoiu, 2008). A
qualitative study conducted in the United Kingdom examined the perceptions of PCPs and
specialists (in this case, community mental health teams) in relation to the role of the specialist
and referral appropriateness (Chew-Graham et al., 2007). There was consensus between
providers over the function of the specialists but confusion over referral criteria. Some referrers
wanted a consultation when they were having difficulty managing a patient; however, most PCPs
agreed that referral criteria would be beneficial. A literature review by De Coster, Fitzgerald, and
Cepoiu (2008) found that rheumatologists and PCPs agreed on the need for early referral for
patients with suspected RA and ankylosing spondylitis (AS), but priority setting criteria do not
currently exist except in cases that would be considered urgent. However, many of the patients
requiring consultation did not fall into this category. The implications of these studies are that
ambiguity is present when PCPs decide to refer patients to specialists and that clarifying the
referral process would be beneficial.
The factors considered when PCPs refer patients to specialty services include
appointment timeliness, quality of specialist communication, and specialist efforts to return the
patient to the primary provider for care (Kinchen, Cooper, Levine, Wang, & Powe, 2004). Since
PCPs consider these factors important, improved communication should be a focus of future
studies in order to investigate the impact on patient outcomes. A review of referral letters
highlighted the need for improved communication, since many referrals made for
musculoskeletal diseases were found to be misdirected, inappropriate, or lacking in essential
information (Newton, Hutchinson, Hayes, & McColl, 1994; Speed & Crisp, 2005). These studies
highlight the lack of agreement between providers regarding what information should be
provided by the referrer.
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Table 2. Current Referral Processes or Guidelines
AUTHOR/
YEAR
ChewGraham,
C., et al.
(2007)
De Coster,
C., et al.
(2007)

DESIGN/
SAMPLE
Qualitative/
35 interviews
with GPs
17 (12 team leaders and 5
psychiatrists)
Literature Review

Kinchen,
K.S., et al.
(2004)

Correlational/1,252
primary care physicians

Newton, J.,
et al.
(1994)
Speed, C.
A., et al.
(2005)

Descriptive/
39 cases referred to ENT
and Rheumatology
Descriptive/
1087 consecutive referral
letters to orthopedic and
Rheumatology

MAJOR FINDINGS
 No existing referral criterion resulting in lack of consistency
 Tension exists between limited resources and clinical
responsibilities
 No single set of priority-setting criteria
 Example of emergent referral- cranial arteritis or systemic
vasculitis; routine referral- fibromyalgia and other soft-tissue
syndromes
 Factors in primary care providers’ choice of referral specialist
include: skill, timeliness, insurance, experience, quality
communication, efforts to return patient to primary physician, and
good patient-specialist rapport.
 Majority of referral letters contained: appropriate patient
identifiers, reason for consult, and information on patient
communication and expectations.
 No diagnosis in 63.4% of referrals.
 58% of orthopedic referrals were considered appropriate
 94% of rheumatology referrals were defined as appropriate

Evaluated Interventions to Improve the Referral Process
Intervention studies have been conducted with the purpose of improving the referral
process between PCPs and specialists. Some researchers have advanced communication and
agreement between the groups through the development of guidelines, but areas for improvement
remain (Rao, Halsey, Bukhari, Dodds, & Mitchell, 2005). Some successful programs developed
referral guidelines by working in conjunction with specialists and PCPs. The guidelines were
then dispensed to local PCPs and made available online (Rao, Halsey, Bukhari, Dodds, &
Mitchell, 2005). Although the guidelines were adhered to over 87% of the time, over 10% of
patients were referred to the wrong specialty (e.g., referred to rheumatology instead of
orthopaedics). This study shows that referral guidelines can help clarify ambiguity for PCPs, but
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specialists will continue to receive some inappropriate referrals. Developing guidelines for areas
that often receive inappropriate referrals (e.g., rheumatology, physical therapy and podiatry)
would be especially beneficial.
Other studies in which PCPs attempted to improve outcomes by assessing severity and
assisting in the development of referral guidelines provide evidence that primary and specialty
care providers need to work together in order to improve this process and allow for prompt care
(Rao et al., 2005; Slade et al., 2008; Watson, 2005). Again, referral guidelines only contribute to
improvement when actually utilized by providers, and they work most effectively when
developed collaboratively between services.
Accurately prioritizing patients through the use of triage systems can also help to
improve wait times. Effective triage systems rely heavily on good communication between the
referring provider and the specialist. New patients are triaged, either by a specialty or referring
provider, and then given a grade based on the ranking of perceived urgency. A prioritization
system (A,B,C) based solely on the information provided in the referral letter found overall good
agreement (k=0.71) between preconsultation and postconsultation grading (Sathi et al., 2003).
However, incomplete or inaccurate referring information is a major barrier to an effective triage
system. When referral letters lacked key information, including a presumptive diagnosis, a
description of involved joints, and a report of symptom duration, 47% of cases received a grade
change after the office visit with a rheumatologist and 17% of these required a higher urgency
grade (Graydon & Thompson, 2008).
An additional benefit of triage systems is identifying inappropriately referred patients
(Harrington & Walsh, 2001). In one study, only 59% of referrals actually required appointments
with rheumatologists, which allowed more timely appointments for patients in need of specialty
13

care (Harrington & Walsh, 2001). These prioritization systems allow specialists to act as
gatekeepers to their practices. If implemented correctly, these systems can contribute to
improved wait times for patients. However, it is important to note that these systems are only
effective when the specialist is triaging patients. When PCPs rate patients on urgency using a
prioritization system, there is low to moderate agreement (kappa = 0.44-0.47, p= .001) with
specialists (Mariotti, Meggio, de Pretis, & Gentilini, 2008). This shows that although referral
guidelines can contribute to improved agreement between providers, ultimately specialists need
to control their prioritization system in order to optimize these systems.
In another study to improve wait times, educational groups were provided for patients in
an attempt to empower the patient and support self-management in order to decrease the amount
of non-essential patients requesting appointment times (Davies et al., 2011). The groups were led
by health care professionals and addressed completing activities of daily living, and personal
pain experiences. Only 48% of attendees requested appointment times after participation in the
sessions which resulted in decreased wait times (Davies et al., 2011). Although it is not clear
whether chronic pain patients are similar to other specialty patients, empowering these patients
with information to care for themselves substantially improved wait times. Other researchers
made attempts to decrease wait times by allowing time for same-day urgent appointments and
improved efficiency by overhauling entire systems (Newman, Harrington, Olenginski, Perruquet,
& McKinley, 2004; Ogunbamise, Reardon, Mohoboob, & Lelliott, 2005). This change was
achieved by lengthening follow-up times for stable patients, hiring additional providers and
allocating one morning every other week to see all new referrals. The referrals were then
discussed post clinic and plans of action were agreed upon and initiated, which significantly
reduced wait times for patients (Newman et al., 2004; Ogunbamise et al., 2005). These studies
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suggests that predetermining appointment times, hiring more providers, and allotting time for
new referrals can help patients receive care in a timely manner.
Table 3. Evaluated Interventions to Improve Referral Process
AUTHOR/YEAR
Davies, S., et al. (2011)

DESIGN/SAMPLE
Prospective Cohort/
319 patients with
persistent pain referred
to a pain clinic

INTERVENTION
Self-Training Educative
Pain Sessions is a sixsession educational program
offered over two days.

Graydon, S. L., et al.
(2008)

Descriptive
Correlational/ 206
referrals

Referral letters triaged for
urgency (A, B, C, D) by
rheumatologist

Harrington, J. T., et al.
(2001)

Descriptive/ 279 new
patients referred to
Rheumatology

Mariotti, G., et al.
(2008)

Correlational/ 488
outpatients who were
referred for
gastroscopy or
colonoscopy

Rheumatologist reviewing
each newly referred
patient’s medical records
prior to
scheduling an appointment
(pre-appointment
management).
PCPs filled out a referral
form using developed
guidelines for homogeneous
waiting groups based on
clinical indications. Each
group (U, A. B, C, E, P) was
assigned a max wait times
of urgent- no limit)

Newman, E. D., et al.
(2004)

Descriptive

Ogunbamise, A., et al.
(2005)

Correlational/ 200
referrals- 100
consecutive referrals
prior to
implementation of
new fast track
assessment (FTA)
system and 100
consecutive referrals

Measured and eliminated
backlog, allowed time for
same-day patients, center
appointment process around
patients, developed
protocols to be used by PCP
Fast Track Assessment all
referrals are discussed at the
weekly meeting. all
individuals, except
emergencies,
are now sent a fixed
appointment
staffed by four or five
members of the team (the
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MAJOR FINDINGS
 Over half did not schedule
an appointment following
attendance.
 Wait times and cost of
new patients were reduced
 96 cases (47%)
experienced a grade
change between referral
and consultation.
 Urgent cases revealed the
absence of a presumptive
diagnosis, symptom
duration, and involved
joints in over 30% of
referrals.
 Only 59% of referred
patients required a
rheumatology consultation

 Poor to moderate
agreement exists between
GPs and specialists in
regards to patients’
priorities.
 Over 22% of referrals
were deemed
inappropriate by
specialists
 The 3rd available
appointment fell from
about 60 days to <2 days.
 Cancellations fell from
40% to <20%.
 Resulted in 1st
appointment offered was
reduced to 18 days from
55 days

post implementation

Rao, C., et al. (2005)

Sathi, N., et al. (2003)

Slade, M., et al. (2008)

Watson, J. M., et al.
(2005)

Descriptive/ 8993
cases were referred for
a musculoskeletal
opinion.
Correlational/ 102
consecutive new GP
referrals

randomized controlled
trial/ 73 practices (408
839 patients) to 11
community mental
health teams
(CMHTs).
Correlational/ 92
individuals with
intellectual disabilities

consultant psychiatrist,
associate specialist two or
three non-medical
professionals). Individuals
booked in 45 min intervals
and assessed by a single
professional
structured ‘core assessment’
pro forma and a simple risk
assessment checklist
Implementing agreed
referral and management
guidelines
Patients received urgency
grade (A, B, C) based on
referral letter then compared
to post-consultation grade.

GPs to complete referrerrated assessment of severity
Threshold Assessment Grid
(TAG) then CMHTs to rate
referral appropriateness
Compare the old referral
system to the new Single
Point of Referral System

 87.2% of musculoskeletal
referrals adhered to the
guidelines.
 Agreement between paper
priorities made by the
consultant on receipt of
the GP’s letter and clinical
priorities made after
seeing the patient in the
out-patient clinic (r = .71).
 Asking GPs to complete a
TAG when referring to
CMHTs did not improve
primary–secondary care
agreement on referrals.
 Waiting times for
appointments improved
from 66 to 6 days (p<.001)
 Number of inappropriate
referrals was reduced
from 26% to 13% (p<.05)

Unevaluated Tools to Improve the Referral Process
There is evidence to support that tools, including referral guidelines, may be essential to
improving the referral process. One example of an effective tool is to include essential elements
in a referral: chief complaint, the reason for the referral, results of laboratory and radiographic
tests, and physical examination results. This can improve continuity of care and communication
between providers (Berta et al., 2009). Guidelines have also been developed to assist PCPs in
identifying and referring patients with suspected early RA: the presence of more than three
swollen joints and morning stiffness lasting greater than 30 minutes (Emery et al., 2002). An
16

additional tool, the Priority Referral Score (PRS), was developed by a clinical panel of
rheumatologists and PCPs to identify the urgency with which a patient needs to be evaluated
(Fitzgerald et al., 2011). Points are assigned for each level selected under the criteria for a
potential total of one hundred points. The higher the score, the more urgently the patient needs to
be seen for evaluation and treatment. The tool was evaluated by other practitioners which
resulted in acceptable interrater (ICC=.80) and intrarater (ICC=.83) reliability. Long wait times
in Canada led to the development and use of priority rating scales in patient populations
(Noseworthy, McGurran, & Hadorn, 2003). These scales, although not curative, are supported by
the public in order to improve wait list times for those with greater urgency. These tools and
guidelines were developed in an attempt to improve the referral process. Although not all of
these tools were developed for rheumatology, some may be beneficial if implemented by
rheumatology clinics experiencing long wait times.
Table 4. Unevaluated Tools to Improve the Referral Process
AUTHOR/YEAR
Berta, W., et al.
(2009)
Emery, P., et al.
(2002)

Fitzgerald, A., et
al. (2011)

Noseworthy, T.,
et al. (2003)

DESIGN/
SAMPLE
Systematic Review
Literature Review

Correlational/ 14
rheumatologists, 10
PCPs reviewed 16
modified case
scenarios
Descriptive/ Clinical
panels constituted in
5 clinical areas

MAJOR FINDINGS
 15 essential components of a referral (ex. demographics, problem,
labs/assessment findings, therapy, plan of care)
 Rapid referral to a rheumatologist is advised for suspected RA.
 This may be supported by the presence of any of the following: >3
swollen joints, metatarsophalangeal/
metacarpophalangeal involvement, and morning stiffness of >30
minutes
 Priority Referral Scale developed to improve referrals from primary
care to rheumatology; Correlation between pre and post
consultation scores were 0.80 and 0.81 for the rheumatologists and
PCPs.
 Point-count scoring systems were constructed to prioritize
waitlisted patients.
 Tool had evidence to support face validity and a pragmatic scoring
system.
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Discussion
The literature presented in this review highlights the numerous problems that exist in
current referral systems for specialty care, which can be attributed to the lack of guidelines for
referral. PCPs often experience a great deal of uncertainty when deciding on appropriate referrals
for specialists. Although it appears that there is greater agreement between providers when
identifying urgent cases, most cases are not considered urgent (De Coster et al., 2008). An
analysis of communication between providers revealed a lack of consistent, pertinent information
conveyed from the PCP to the specialist; clearly communication between providers must be
improved (Newton et al., 1994; Speed & Crisp, 2005). Although there is disagreement on how
to make care timelier, there is agreement that long wait times and delays in care are detrimental.
Tools and guidelines that have been developed to help improve communication aim to
identify those patients who need to be seen urgently in order to give them prompt medical
attention (Newman et al., 2004; Rao et al., 2005; Sathi et al., 2003). Examples include referral
guidelines, prioritization systems, and urgency scales. Evaluated interventions indicate that
prioritization systems, when implemented by specialty practices, can improve wait times and
referral processes (Sathi et al., 2003). Other interventions that were shown to be beneficial
include preappointment educational sessions (Davies et al., 2011), allocating blocked time for
new referrals, collaboratively developed referral guidelines, and predetermined appointment
lengths (Slade et al., 2008).
Although research has been aimed at evaluating referral systems utilized between
primary and specialty care, no one system has been shown to work across all disciplines. It is not
clear whether these systems are as effective in other specialty areas. In general, triage systems
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are effective at reducing wait times and identifying acutely ill patients, but systems should be
tailored to meet the specific needs of that patient population. Other gaps in knowledge include
identifying the cause of inappropriate referrals. It is unclear whether these referrals are due to the
PCP’s misunderstanding of the scope of specialty practices, or to misdiagnosis of the patients.
Additionally, clinics that experience high rates of unexpected cancelations or patients who do not
attend scheduled appointments may require an alternate solution in order to address the problem.
There are some limitations of the reviewed articles to consider. Since no date limitation was used
some of the articles are well over ten years old. Additionally some of the articles had small
sample sizes. Expert opinion was used in the development of many of the tools and guidelines
reviewed.
Future research should be directed at continued evaluation of such systems. However,
improving access to care requires a multi-method approach as no single intervention will be
sufficient to adequately improve the increasing supply and demand mismatch. The existing
evidence strongly supports that the key elements necessary for improvement are: the
development of referral guidelines in which primary and specialty care providers collaborate and
the development of the patient prioritization systems to be utilized by specialty care clinics.
Conclusion
In the context of an increasing mismatch between patients’ timely treatment and the
availability of specialty providers, accurate referrals to enable specialist triage and ensure timely
treatment are vital. This literature review highlights the crisis of overwhelmed specialty care
areas related to the growing prevalence of persons with rheumatic diseases without an increase in
the number of rheumatologists (Helmick et al., 2008). The evidence suggests that there are health
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benefits to receiving treatment from a specialty provider, including earlier initiation of
recommended pharmacological interventions for some of the rheumatic diseases including RA
(Möttönen et al., 2002; Yelin et al., 1998). More research is required in this area as patients who
are started on medications earlier in their disease get older and further comparison can be made
as to the effectiveness of earlier treatment by specialty care providers.
The reviewed studies point to lack of communication, understanding, and agreement as
reasons for the discontinuity between primary and specialty care (Mariotti et al., 2008; Newton et
al., 1994). Certainly the providers have different priorities and knowledge when identifying
appropriate referrals. In addition, there is inconsistency surrounding what information constitutes
a referral (Speed & Crisp, 2005). Guidelines on RA seem to be widely accepted and utilized.
However, there is a broad range of musculoskeletal diseases that exist without similar guidelines
for PCPs. A need for the development and use of such guidelines is clearly highlighted
throughout the literature.
Other methods to improve efficiency in the referral process include development of
prioritization triage systems (Graydon & Thompson, 2008; Harrington & Walsh, 2001). These
systems require a specialist to review patient information and decide how urgently the patient
needs to be seen. These systems require refinement but certainly improve wait times for the
majority of urgent patients. They can also identify inappropriately referred patients, who can
then be redirected to appropriate specialties, thus eliminating them from filling the high-demand
appointment slots (Harrington & Walsh, 2001). While increasing the number of providers is an
obvious strategy to decrease wait times for patients seeking rheumatologic care, improving
efficiency in the flow of the appointment timing can also be beneficial. In addition, evidence
supports that referral guidelines specifically improve communication and agreement between
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providers (Fitzgerald et al., 2011). Thus, implementation of several strategies including
development of referral guidelines, patient prioritization triage systems, and efficient clinic work
flow may be required to adequately address the problem.
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Abstract
1.3 million Americans are diagnosed with Rheumatoid Arthritis (RA). Early diagnosis and
treatment of RA is essential to optimize patient outcomes. The inflammation that leads to
permanent damage can now be significantly reduced with early pharmacological intervention.
However, many patients do not receive diagnosis or treatment in a timely fashion due to delayed
disease recognition and significant wait times for appointments with a rheumatology specialist.
Patients with early signs of RA often present initially in primary care, thus it is critical that
primary care providers are aware of and deliver care consistent with current, evidence based
standards of care. This article summarizes current guidelines for recognition and management of
RA for first contact providers which have been developed by the two leading organizations for
RA: National Collaborating Centre for Chronic Conditions (NCC-CC; 2009) and American
College of Rheumatology/European League against Rheumatism (ACR\EULAR; 2010).

Key Points:


Early recognition and treatment of RA by PCPs may reduce patient morbidity and
mortality



A thorough history & physical should include impact on activities of daily life, duration
of symptoms and evaluation of large and small joints



Initial diagnostic tests ordered by the PCP must include: at least a RF, Anti-CCP , and
CRP or ESR; X-rays of affected joints



Ensure influenza and pneumonia vaccines are up to date on patients taking DMARDs;
avoid live vaccines if on biologics
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Introduction
Rheumatoid Arthritis currently affects an estimated 1.3 million U.S. adults eighteen and
older and as much as 1% of the world population (Helmick et al., 2008). It is not known how
many patients suffer without treatment or are in the early stages of the disease and have yet to be
correctly diagnosed. However, in some areas patients average over sixteen months between
symptom onset and consultation with a provider (Rodríguez-Polanco, Al Snih, Kuo, Millán, &
Rodríguez, 2011). When patients do seek care, they most often initially present to a primary care
provider (PCP) with complaints of joint pain and stiffness and are then referred to rheumatology
for specialist care (Conditions, 2009). This means that PCPs often serve as the first contact with
the health care system and thus have an important opportunity to recognize early symptoms and
facilitate early treatment.
RA is a progressive and incurable autoimmune disease that attacks the synovial
membrane of joints resulting in swelling and pain (Crowther-Radulewicz & McCance, 2013). As
the disease progresses, swelling spreads to cartilage, tendons, and ligaments producing
significant discomfort, deformity and loss of function. Joints that are most commonly attacked
are those essential in carrying out activities of daily living including those in hands, feet, elbows,
and knees. Fever, malaise, lymph node enlargement, and Raynaud’s phenomenon are also seen
in these patients (Crowther-Radulewicz & McCance, 2013). Patients with RA are also at
increased risk of developing cardiovascular disease and osteoporosis due to disease activity and
medication side-effects (West & West, 2014).
RA affects women more frequently than men at a 3:1 ratio and is more prevalent in those
over the age of thirty years (Crowther-Radulewicz & McCance, 2013). The cause of this
debilitating disease remains unknown but there is believed to be a reproductive and hormonal
24

component which explains the higher prevalence in women. Genetic susceptibility and an
initiating event such as an infection are thought to trigger the extreme immune response
(Crowther-Radulewicz & McCance, 2013). When left untreated, the persistent inflammation
from RA can lead to irreversible joint damage and therefore, disability contributes to the
mortality and morbidity for this population (Oliver & St. Clair, 2008).
Prompt treatment is necessary to reduce permanent joint destruction. These patients may
experience symptoms at home for several months prior to seeking care. Then a correct diagnosis
must be made by the first contact provider in order to receive a referral to a rheumatology
specialist. Unfortunately, patients often face substantial wait times for an appointment with a
specialist because many clinical areas treating rheumatic diseases are already strained due to a
supply and demand mismatch where the prevalence of patients with arthritic conditions seeking
treatment far exceeds the supply of available rheumatology providers (Deal et al., 2007).
Currently, typical wait times for an appointment with a rheumatology provider are in the range of
34 to 48 days and this wait is expected to get even longer because of a projected shortage of
2,609 rheumatologists by 2025, causing more delays in care which can lead to even more
adverse health outcomes for patients with RA (Deal et al., 2007; Kirwan, 1997). In a typical
scenario, a patient with suspected RA often waits a few months before seeking treatment from
their PCP because they think the pain will be self-limiting. When the pain does not resolve and
they are first evaluated by their PCP, they often have to wait an additional five to seven weeks
before initiating treatment with the rheumatologist; as a result, several months can pass between
onset of symptoms and initiation of important medications. Earlier prescribed pharmacological
interventions are now the standard of care for RA, including disease-modifying antirheumatic
drugs (DMARDs) within the first three to six months of disease onset (Lippincott's Illustrated
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Reviews:Pharmacology, 2012). Timely care can slow disease progression and improve quality of
life, thus it is imperative that primary care providers are able to recognize and begin initial
management for patients with suspected RA.
Because of the number of patients requiring treatment and the relatively low number of
health care providers who have specialized in rheumatology, systems to screen and prioritize
patients are often used to make the referral process more effective (Pincus et al., 2002).
Symptoms, lab work, radiographs, and histories are evaluated by specialty providers so that
urgent patients are scheduled promptly; thus it is important that primary care providers are
gathering and submitting appropriate information in a timely manner so that patients with RA
can be most effectively triaged. Failure to do so can further delay treatment for patients that are
experiencing symptoms which can not only decrease quality of life but lead to permanent
destruction and functionality of the joints. The more complete and accurate the referral
information is, the more likely the patient will receive an appropriate appointment time for the
patient’s need. Therefore, the purpose of this paper is to summarize the most current evidence
based standards for initial evaluation and treatment of patients with suspected RA. These
guidelines have been put forth by the 2009 National Collaborating Centre for Chronic Conditions
(NCC-CC) and 2010 American College of Rheumatology/European League Against
Rheumatism (ACR\EULAR) for the evaluation and treatment of RA and provide suggestions for
practice implementation for primary care providers (Aletaha et al., 2010; Conditions, 2009).
Clinical Practice Guidelines
There are currently two guidelines that can be utilized by PCPs to help guide care for
patients with suspected RA. One guideline was developed by the NCC-CC (2009) on behalf of
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the National Institute for Health and Clinical Excellence (NICE) and the other by the American
College of Rheumatology (ACR) and European League against Rheumatism (EULAR; 2010).
Although both guidelines encompass the diagnosis and management of the disease at the
rheumatology specialist level, both include practice guides relevant to primary care to assist in
the early diagnosis and referral of patients with suspected RA.
The NCC-CC guideline (2009) was developed by an expert panel to be a userfriendly evidence based clinical practice guide. Similarly, the ACR and EULAR (2010) formed a
joint committee of expert members who determined goals that included identifying those at high
risk for developing erosive disease and when to initiate DMARD therapy. This updated the 1987
ACR classification of RA by refocusing on earlier stages of the disease rather than later
manifestations. The new guidelines state that synovitis in at least one joint that is not better
explained by another diagnosis should be considered for classification. This is different from the
1987 criteria which placed significance on later clinical manifestations of disease progression
(e.g., erosions).
Both the NCC-CC and ACR/EULAR guidelines now focus on the early recognition and
prompt care including pharmacologic intervention for patients with RA. Guidelines have shifted
the focus on identifying and intervening early in the disease with medications in order to prevent
the deformities and physical impairments that are often present with untreated late stages of RA.
However, there are some differences between them. The NCC-CC guideline seems to be more
user-friendly and is intended to be used by all providers and patients with RA, including PCPs.
The ACR/EULAR guideline is intended to accurately identify those with RA specifically for
rheumatologists, rather than for use by patients or PCPs as a referral tool. However, many of the
recommendations, particularly related to the initial stages of diagnosis and treatment, are relevant
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to PCPs and can be used by them to correctly identify, assess and refer patients with an
unexplained inflammatory arthritis.
Specific recommendations
History & Physical Assessment
For patients complaining of joint pain, a complete history should be taken to determine if
any systemic manifestations have been present even if none are evident during assessment (Table
1). The PCP should ascertain if there has been any recent trauma that could explain the pain,
swelling or stiffness and ask the patient to identify involved joints and the duration of symptoms.
It is essential for the practitioner to inquire about morning stiffness and the amount of time
required before the patient feels like their joints “loosen up” as much as possible for the day.
Information on the extent of disability and impairment on activities of daily living should also be
explored (Oliver & St. Clair, 2008). The disease may be impacting the patient’s work and
recreational activities, which can lead to a significant decrease in quality of life and financial
strain. Self-report measures can be used to evaluate disease activity, such as the Health
Assessment Questionnaire Disability Index (HAQ-DI) which is an assessment tool to help
quantify a person’s functional ability (Bruce & Fries, 2003). It assesses different categories of
functioning including hygiene, grip, and feeding. It can be administered at different points during
disease progression to gauge disease activity and response to treatment.
A thorough physical assessment must include location of affected joints, and signs of
pain and swelling (Oliver & St. Clair, 2008). Each joint should be inspected and range of motion
tested. Large joints including the shoulders, hips, knees, ankles, elbows as well as small joints
including the metacarpophalangeal (MCP), proximal interphalangeal (PIP), and wrists should be
visualized and palpated. Observation of visible effusions and rheumatoid nodules over surfaces
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or bony prominences should be documented. Assessment of systemic symptoms is indicated
including fatigue, discoloration of the hands, dry mouth or eyes, or chest pain. Serious systemic
complications are rare but can include interstitial lung disease, pericarditis, and vasculitis (Oliver
& St. Clair, 2008).
Table 1. Key Information to obtain during History & Physical of Patients with
Possible/Suspected Rheumatoid Arthritis

History
Recent trauma
Duration of morning stiffness
Impact on ADLs
Joints affected
Duration of symptoms
Fatigue
Chest pain

Physical
Inspection of affected joints- effusions or nodules
ROM of joints
Discoloration of hands
Dry mouth or eyes
Heart sounds
Breath sounds

Initial Diagnostic Tests
Both guidelines recommend that patients with possible/suspected RA have some
laboratory studies obtained (Aletaha et al., 2010; Conditions, 2009). A referring provider must
obtain at least a rheumatoid factor (RF) which is useful in the diagnosis but not to gauge disease
severity or activity. RFs are autoantibodies, antibodies that attack host tissues, and can consist of
two classes of immunoglobulins (Crowther-Radulewicz & McCance, 2013). Seventy five to 85%
of RA patients will have detectable RF levels at some point throughout their disease while only
50% will be positive in the first six months of disease activity (Oliver & St. Clair, 2008). Other
chronic inflammatory states or diseases can also cause detectable RFs including hepatitis C so if
a patient has a positive RF a PCP should consider a hepatitis panel as well. One difference in the
terminology used by the two groups is the NCC-CC guidelines recommend anti-cyclic
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citrullinated peptide antibodies (anti-CCP) while the ACR/EULAR guidelines recommend anticitrullinated protein antibodies (ACPA). The ACPA is tested with the anti-CCP serum test since
anti-CCP recognizes multiple citrullinated proteins. (Aletaha et al., 2010; Conditions, 2009;
Ioan-Facsinay et al., 2010). So, although the terminology is different both groups recommend the
anti-CCP serum test since these autoantibodies are believed to contribute to the development of
RA (Oliver & St. Clair, 2008). Anti-CCP has a sensitivity of 70% but a superior specificity of
95% compared to RF; as many as 35% of RA patients will initially test negative for RF but
positive for anti-CCP (Oliver & St. Clair, 2008). This is why it is beneficial to obtain both RF
and anti-CCP when RA is suspected. However, these serum labs are not required for a diagnosis
to be made but can contribute to the working diagnosis. Also, no serial testing is indicated since
repeating these labs does not correlate with disease progression or response to treatment.
Table 2. Recommended Lab Work & Radiographs for Suspected RA
Upon presentation of inflammatory arthritis with no other explanation, order the following:
Rheumatoid Factor (RF)
Anti-cyclic citrullinated peptide (anti-CCP)
C-reactive protein (CRP) AND/ OR Erythrocyte sedimentation rate (ESR)
Radiographs of affected joints in hands and feet

Acute phase reactants (APRs) are proteins that increase in serum concentration during
times of inflammation or tissue injury and as a result reflect the presence and intensity of an
inflammatory condition such as RA; C-reactive protein (CRP) and erythrocyte sedimentation rate
(ESR) are the most common APRs. At least one APR, either CRP or an ESR, should be
performed by the referring provider. CRP is independent of the hemoglobin concentration and
has a major function that permits recognition of foreign pathogens and damaged cells. This
means several conditions can cause CRP elevation including infection. ESR on the contrary can
be affected by the number of red blood cells and responds slower to patients’ conditions than
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CRP. It is possible that ESR may not rise in early inflammation, thus may be within normal
limits early in the disease process. Although which APR to use is at the discretion of the
provider, CRP is a better choice if the provider believes the patients has recently experienced
initial symptoms. As with RF and anti-CCP, elevated ACPs are not required in order to make a
diagnosis. This is why elevated CRP and ESR levels should only be considered in conjunction
with patient presentation and other blood work.
Radiographic changes in affected joints can be invaluable when diagnosing RA and thus
x-rays of hands or feet are recommended by both groups (Aletaha et al., 2010; Conditions,
2009). Early changes can be noted sometimes within six months of disease activity and is seen
as periarticular osteopenia (Oliver & St. Clair, 2008). Other early changes include bony erosions
and joint-space narrowing. However, uncontrolled RA can lead to subluxation and loss of joint
alignment (Oliver & St. Clair, 2008).
In conclusion, when a patient presents with synovitis of at least one joint that cannot be
explained by another process, the provider should obtain at least a RF, anti-CCP, either a CRP or
ESR, and radiographs of the affected joints.

Table 3. The 2010 ACR-EULAR Classification Criteria for Rheumatoid Arthritis
Patients who:
1. Have at least 1 joint with definite clinical synovitis (swelling)
2. With the synovitis not better explained by another disease
Classification Criteria for RA - Score-Based Algorithm
A. Joint involvement
1 large joint
2-10 large joints
1-3 small joints (with or without involvement of large joints)
4-10 small joints (with or without involvement of large joints)
>10 joints (at least 1 small joint)
B. Serology
Negative RF and negative ACPA
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Points
0
1
2
3
5
0

Low-positive RF or low-positive ACPA
High-positive RF or high-positive ACPA
C. Acute-phase reactants (at least 1 test result is needed for classification)
Normal CRP and normal ESR
Abnormal CRP or abnormal ESR
D. Duration of symptoms
<6 weeks
≥6 weeks
TOTAL SCORE

2
3
0
1
0
1

Scoring: Sum scores from each category. A score of ≥6/10 is needed for classification of a patient as having definite
RA. (Aletaha et al., 2010)

Referral
Specialty evaluation by a rheumatology provider is essential for patients with suspected
RA and thus a rheumatology referral is recommended by both the NCC-CC and ACR/EULAR
guidelines (Aletaha et al., 2010; Conditions, 2009). There is abundant evidence to support the
benefits of early treatment by a rheumatology provider on patient outcomes and earlier
pharmacological intervention with DMARDs (Pincus et al., 2002; Yelin et al., 1998). When
contemplating a referral, a provider can use the 2010 ACR/EULAR RA classification system
(Table 3) to help determine if RA is a likely diagnosis and if a referral is indicated. A score
greater than or equal to six would indicate a RA diagnosis. Since a goal of treatment is to initiate
care early, a provider does not have to wait until a score of six to refer but should definitely
consider specialty consultation if a patient’s score is elevated.
When completing a referral, it is important that the PCP completes an accurate history
and physical, with particular attention to key components/systems/anatomy previously described,
obtains initial lab and diagnostic tests (RF, anti-CCP, APR, and x-ray), and provides complete
and accurate documentation to the specialist.
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Medications
There are a number of important medications used in RA including DMARDs, biological
agents, and glucocorticoids (Aletaha et al., 2010; Conditions, 2009). However, many of these
medications can alter labs including APRs that are considered for diagnosis and the referring
practitioner should consult with the rheumatology provider before initiating these regimens. A
course of analgesics or NSAIDS may be initiated by the PCP to help with symptom control until
the patient consults with the rheumatologist.
Although the PCP typically will not prescribe DMARDs, biological agents, or
glucocorticoids, it is very likely that they will be caring for patients taking these medications and
thus it is important that they understand the properties of these medications as well as potential
side effects and/or possible interactions with other medications. It is beyond the scope of this
article to thoroughly describe these medications; however, a brief description of each drug class
with common side effects and special considerations (including interactions to common
medications) that are important for the PCP to know has been presented in an article by Dunkin
(2014).
DMARDs.
Most rheumatology specialists will initiate therapy with first-line drugs such as
methotrexate or hydroxychloroquine when there are no contraindications (West & West, 2014).
DMARDs can help stop the destructive progression of RA when initiated early in the disease
process (Lippincott's Illustrated Reviews:Pharmacology, 2012). This drug should be selected
based on patient profile and characteristics; sometimes several drugs may be trialed prior to
finding the most appropriate for a specific patient. In general, these drugs are typically effective
and safe.
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Biologics.

The Biologics are given orally , by injection, or IV infusion and are the newest treatment
for RA (Lippincott's Illustrated Reviews:Pharmacology, 2012). Some of the biologics, known as
TNF-inhibitors (etanercept, adalimumab, infliximab, golimumab, certolizumab) greatly improve
patients’ symptoms, reduce destruction and thus improve function (West & West, 2014). They
carry an increased risk of TB and herpes zoster so live vaccinations (MMR, varicella/zoster,
flumist) should be avoided (Vivar & Van Vollenhoven, 2014). They are often used in
conjunction with other DMARDs especially methotrexate and also have an increased risk of
infection. However, patients often feel improvement as soon as four to six weeks. Anakinra,
abatacept, rituximab, and tocilzumab are other biologics that are used generally if response to
DMARD therapy is inadequate. Although DMARDs and biologics have different mechanisms of
action, they slow the progression of the disease and improve patients’ symptoms and quality of
life (West & West, 2014).

General Considerations for Patients taking Anti-Rheumatic Medications.

Some general considerations include that all of these medications lead to an increased
risk of bacterial and viral infections. Vaccinations including influenza, pneumonia, hepatitis B,
zoster, and human papillomavirus (HPV) should be given prior to initiation when possible (Singh
et al., 2012). However, they may be administered during treatment with the exception of the
zoster vaccine. All live vaccines are contraindicated if a patients is receiving a biologic (Singh et
al., 2012). Additionally, it often takes three to four months for patients to experience the full
effect of the medication, thus pain may be an issue addressed by the PCP in conjunction with the
rheumatology specialist.
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Implications for Practice and Follow-up

Both practice guidelines offer evidence-based strategies to prevent or decrease further
disease activity including not only a referral to a rheumatology specialist, but other
multidisciplinary treatment (Aletaha et al., 2010; Conditions, 2009). Occupational therapy,
podiatry and nutritional consultation and mental health counseling are frequently indicated to
improve quality of life. Complementary therapies may also be utilized by patients including
acupuncture and aromatherapy (Conditions, 2009).
While a rheumatology provider will manage the RA condition, the PCP plays an
important role in a patient’s overall care and provides a complementary role by following and
reinforcing the specialist’s RA treatment plan and ensuring that aspects of care that fall within
his or her scope of practice are delivered. For example, ensuring vaccinations are up to date
(especially important for patients receiving immunosuppressant medications), providing
education about the disease and strategies to decrease risk of infection, and answering questions
are all tasks important to the ongoing care of these patients. PCPs can aid in the early
identification of cardiovascular risk factors including hypertension, hyperlipidemia, and smoking
then initiate recommended treatment and follow-up to help decrease the risk of atherosclerosis.
This is imperative since cardiovascular disease is the most prevalent cause of mortality for
patients with RA (West & West, 2014). Additionally, PCPs should be aware that cardiovascular
disease develops on average five to ten years earlier than in the general population (West &
West, 2014). Similarly, monitoring vitamin D and calcium levels, recommending
supplementation when necessary, and obtaining a bone density scan when indicated can help
prevent the development of osteoporosis in this population. The PCP can also monitor the patient
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during other routine appointments and facilitate communication with the rheumatology provider
if the patient is experiencing problems.
Awareness of best practice is vital when caring for patients with a suspected or confirmed
RA diagnosis and implementation of the evidence-based practice guidelines summarized in this
paper can help facilitate optimal care and a smooth referral process between primary care and
specialty providers. PCPs have the ability to directly impact the initial and ongoing treatment of
patients with RA and thus can influence the progression or non-progression of the disease and
subsequent disability or other complications and overall quality of life. When working in
collaboration with rheumatology providers and patients, PCPs are important members of the
health care team and can help decrease the risk of complications to maximize patient outcomes
and quality of life.
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Abstract
Background: The discordance between the numbers of rheumatology providers relative to
persons seeking care has resulted in significant periods of time in which patients wait for care.
Patient prioritization systems have been used to triage referred patients to facilitate timely
treatment of acutely ill patients, but there is limited data to support the effectiveness of these
systems as implemented in the clinic setting.
Methods: A prospective study design was conducted among adult patients referred to a large
university rheumatology clinic (N= 103) to compare the pre- and post-appointment providerassigned, triage-system acuity scores. Data were collected from May through September of 2014.
The intra-class correlation coefficient (ICC), paired t-test, and the Bland-Altman plotting method
were used to compare acuity scores and summarize the findings.
Results: The ICC between the pre- and post-appointment acuity scores was 0.50 (p < .001). The
average difference between the pre- and post-appointment acuity scores was not significant (t = 1.17; p = .24). The Bland-Altman plot suggests the pre- and post- appointment patient triage
scores were typically within the limits of agreement; only 8 of the 103 score differences were
outside of the limit of bias (± 2 SD). Compared with the pre- scores, three patients were given a
higher acuity score and five patients were given a lower acuity score following their clinical
evaluation.
Conclusion: Our findings suggest the specialty-provider triage system evaluated is effective at
accurately classifying rheumatologic patient acuity. When resources are limited and delayed
evaluations and treatments result in negative health outcomes, the use of triage systems is likely
an effective strategy to reduce the impact of limited provider availability relative to patient
census.
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Introduction
Rheumatology is an Internal Medicine sub-specialty focusing on the treatment of a vast
number of pain, autoimmune, degenerative, and inflammatory conditions (e.g., rheumatoid
arthritis, osteoarthritis, fibromyalgia, systemic lupus erythematosus). Many of these
rheumatologic conditions are often classified as arthritic. In the U.S., there were 4,946
rheumatologists charged with treating the population of persons with rheumatic conditions,
which is estimated to be over 48 million (2005) (Centers for Disease Control and Prevention,
2009; Helmick et al., 2008; Lawrence et al., 2008). With an expected increase in the prevalence
of arthritic conditions, a shortage of 2,609 rheumatologists by 2025 is projected (Deal et al.,
2007; Kirwan, 1997).
This shortage of rheumatologists relative to the number of persons seeking care results in
significant wait times for rheumatology clinic appointments. An estimated six to seventeen
months elapse between a rheumatology patient's first symptoms to his or her rheumatology
appointment (Hernández-García et al., 2000; Kumar et al., 2007). Timely diagnosis and
treatment of rheumatologic conditions is imperative for optimal treatment and delays in care
result in worsened health outcomes including permanent damage to organ systems increasing
morbidity, mortality, and rates of disability (Oliver & St. Clair, 2008; Yelin et al., 1998).
To address the disporpotionate need for rheumatology care relative to the supply of
rheumatology health care providers, many rheumatology practices use patient-triage systems.
These systems identify referred, acutely-ill (urgent need for an appointment) rheumatology
patients and prioritize their care in order to provide time-appropriate treatment (Sathi et al.,
2003).
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A number of specific triage systems are used by rheumatology and other specialty
practices where the need for services outweighs the number of available providers. Triage
systems can be grouped into those triaged by a specialty provider (Graydon & Thompson, 2008;
Harrington & Walsh, 2001; Sathi et al., 2003) or by the referring provider (Slade et al., 2008).
Typically those systems in which new referrals are triaged by a specialty provider involve review
of referral information by a provider trained in rheumatology who then assigns a score based on
the patient’s rheumatologic acuity (Graydon & Thompson, 2008; Harrington & Walsh, 2001;
Sathi et al., 2003). Appointments are scheduled based on the acuity score considering
appointment availability (Harrington & Walsh, 2001; Slade et al., 2008). These systems also
identify patients who were inappropriately referred to rheumatology or the outpatient setting and
redirect them to appropriate services (Harrington & Walsh, 2001). Systems in which referrals
were triaged by the referring provider for outpatient specialty services involve referring
providers assigning patients a score based on urgency for outpatient services (Mariotti et al.,
2008). The patients are then given appointment times with maximun waiting intervals based on
the score (Mariotti et al., 2008). Both systems aim to identify acutely ill patients and reduce wait
times for those patients that need to be seen urgently.
There is conflicting evidence on the accuracy of patient triage systems at correctly
classifying acutely ill patients. Evaluation of prioritization systems in which patients were
triaged by a rheumatology provider suggest good agreement between pre- and post-consultation
score (kappa = 0.71); yet the efficacy of these triage systems is hinged on accurate information
from the referring provider (Graydon & Thompson, 2008). Evaluations of referring-provider
systems have suggested poor to moderate agreement (kappa = 0.44-0.47, p= .001) between the
referring and consulting provider (Mariotti et al., 2008; Slade et al., 2008).
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In summary, the inequity between the high number of persons with rheumatic conditions
and the few specialty providers available to provide this population with specialty care has
resulted in the use of patient-prioritization triage systems, which aid in identifying and providing
timely treatment to high-acuity rheumatologic patients. The dearth of and conflicting research
findings in regards to these systems has resulted in a lack of a standardized, evidence-based
triage system; therefore further research is needed to improve quality in patient care. Therefore,
we conducted a prospective study to compare the pre- and post-appointment provider-assigned,
triage-system acuity scores assigned using a patient prioritization triage system at a
rheumatology clinic in a large university medical center.
Description of the Current Triage System
The patient prioritization triage system evaluated consisted of a board-certified
rheumatologist reviewing documents sent by a referring provider and then assigning an acuity
score; thereby determining rheumatology appointment immediacy. Acuity score levels ranged
from 1 to 4, with lower scores indicating more urgency: (1) urgent (e.g., systemic vasculitis); (2)
emergency (e.g., active inflammatory arthritis); (3) next available (e.g., stable inflammatory
arthritis); and (4) lowest priority (occupational musculoskeletal condition). Additional health
information was often requested from the referring provider (i.e., lab results, office notes) and
then re-reviewed. The acuity score was entered into a secured, Health Insurance Portability and
Accountability Act-compliant World Wide Web-based database (Sharepoint®). This Web-based
database contained key information provided by referring providers (including date of referral,
lab results, key assessment findings, and pertinent medical history). The database also contained
information entered by the rheumatology department, including acuity score, presumptive
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diagnosis, and date of appointment. Appointments were made by a scheduling center based on
the pre-appointment acuity score.
Methods
Approval was granted from the university Medical Institutional Review Board. A written
informed consent was given to all of the providers explaining the study and to request their
participation.
Sample and Setting
All persons newly referred to the university rheumatology clinic from an outside facility
age 18 or older between May 2014 and September 2014 who were provided a pre-appointment
acuity score were eligible for inclusion in the study. The sample comprised 103 adults who met
inclusion criteria.
Protocol
Pre-appointment acuity scores were obtained from a Sharepoint® system used by the clinic
prior to the initiation of the study. To evaluate the accuracy of the score, providers were asked to
score patient acuity using the triage scoring system following the initial consultation. All
information was de-identified by clinic staff who assigned patients a participant number prior to
the patient being seen for consultation entered data into an Excel© spreadsheet which was
provided to the research team. This information included: date of referral, age, gender, county of
residence, scheduled rheumatology provider, appointment date, and presumptive diagnosis. Data
collection sheets (with the de-identified patient number assigned by clinic staff) were given to
providers after their initial consultation with patients; these sheets asked the provider to assign the
patient a post-appointment acuity score and document a presumptive diagnosis based on the
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information gathered during the consultation. This de-identified information was then entered in
the Excel© spreadsheet with the corresponding pre-appointment acuity scores and demographic
information collected prior to the appointment by clinic staff.
Analysis
Descriptive statistics, including means and standard deviations or frequency distributions, were
used to summarize demographic and clinical characteristics of study participants. To evaluate the
efficacy of the triage system, the Bland-Altman method was implemented and included an intraclass correlation coefficient (ICC), a paired t-test and Bland Altman plot (Altman & Bland, 1983;
Martin Bland & Altman, 1986). ICC was used as the test of association to determine the
correlation between pre- and post-acuity scores. The paired t-test was used to determine whether
the average difference between the pre-appointment acuity score and the post-appointment acuity
score was significantly different from zero (Rayens, Svavarsdottir, & Burkart, 2010). The
Bland-Altman plot was used as a graphical way of depicting agreement between the acuity
scores by assessing differences between the “gold-standard” or most accurate rating (postappointment acuity score) and triage system (pre-appointment acuity score) (Rayens et al.,
2010). Data analysis was performed using Statistical Package for the Social Sciences (SPSS©)
21 software; an alpha level of .05 was used to determine statistical significance.
Results
Summaries of patient demographic and clinical characteristics are displayed in Table 1.
The mean age of participants was 46.1 years (SD = 13.3; range = 18-85). Consistent with
rheumatologic disease in the U.S., the majority of the sample was female (81%) (Klippel et al.,
2008). Patients waited an average of 36.5 days (SD = 15.8) from the time of outside provider
referral until their initial clinic consultation. The predominant working rheumatology diagnoses
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included osteoarthritis (34.9%), fibromyalgia syndrome (24.3%), rheumatoid arthritis (16.5%),
and systemic lupus erythematosus (3.8 %).
Table 1. Demographic and clinical characteristics of study participants (N = 103)

Mean (SD); range
or n (%)

Age (years)

46.1 (13.3); 18 – 85

Gender
Male
Female

20 (19.4%)
83 (80.6%)

Time from referral to appointment (days)

36.5 (15.8); 3 – 105

Predominant Working Diagnoses
Osteoarthritis
Fibromyalgia syndrome
Rheumatoid Arthritis
Systemic Lupus Erythematosus

36 (34.9%)
25 (24.3%)
17 (16.5%)
4 (3.8%)

Pre-appointment acuity score

3.3 (0.7); 2 – 4

Post-appointment acuity score

3.4 (0.9); 0 – 4

The ICC for the acuity scores was 0.50 (p < .001), which suggests moderate agreement
according to the guidelines established by Landis and Koch (Landis & Koch, 1977). There was
not a significant difference between the pre- and post-appointment acuity scores according to the
paired t-test (t = -1.17; p = .24). The Bland-Altman plot (Figure 1) suggests that the pre- and
post- appointment triage scores were within the limits of agreement; only 8 of the 103
differences were outside of the limit of bias (± 2 SD). Three patients were given a higher acuity
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score and five patients were given a lower acuity score following their clinical evaluation
(relative to their triage acuity score prior to being seen in the clinic).

n=1
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Figure 1. Bland-Altman Plot

2.0
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3.5
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Average acuity score

Note: Bland Altman plot showing the directional differences in pre-appointment and postappointment acuity scores, the average bias and limits of agreement (N = 103).
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Discussion
The specialty provider prioritization triage system evaluated in this study was effective in
identifying acutely-ill rheumatologic patients as evidenced by the moderate agreement found
between the pre- and post-appointment acuity scores (ICC = 0.50). Paired t-tests results found no
significant difference between the means, and only 7.8% of the scores fell outside of limits of
agreement as shown on the Bland-Altman plot. This is consistent with other research aimed at
evaluating the accuracy of similar triage systems (Sathi et al., 2003). Sathi and colleges (2003)
found that good agreement (kappa = 0 .71) existed between scores based on the referring
information and those after consultation. Importantly, most scores that were different between
the pre- and post-assessments were due to a lower priority assigned at post-assessment,
suggesting that acutely ill persons received timely care.
Despite the triage systems being used and inappropriate referrals being redirected to
appropriate services, we found that patients still waited on average 37 days before being seen by
a rheumatology health care provider. This is important considering that up to 41% of patients
requesting consultation with a rheumatology provider are inappropriate; thus, wait times would
have likely been significantly longer had this system not been in place (Harrington & Walsh,
2001). Because accuracy in referring information is imperative in order to receive an appropriate
acuity score (i.e., the lack of a presumptive diagnosis, symptom duration and involved joints can
lead to acuity ill patients receiving lower acuity scores), future studies should aim to develop
quality improvement strategies to improve the accuracy and efficiency in which health
information is provided from referring providers to sub-specialties (Graydon & Thompson,
2008).
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The time required to implement the prioritization triage systems is an additional
limitation to wide-spread use. Future studies should be directed at making system improvements
to advance feasibility by streamlining the process of assessing and recording this information.
When designing this study, we felt it was important to evaluate the prioritization triage
system as it was implemented in the rheumatology clinic setting. However, some limitations
were present because of this approach to conducting the study. In this clinical setting, the preand post-appointment triage acuity scores were often assigned by different providers. This may
have contributed to variability despite the use of a standardized scoring system. Because of the
time lag in appointment wait times, it is possible that patient acuity changed over the time that
elapsed between the initial acuity score to when the patient was seen in the rheumatology clinic.
For this reason, the comparison of pre- and post-assessment acuity is conservative since some
discrepancy may be due to patient status changes rather than errors in acuity measurement.
Conclusion
This study indicates that there is agreement between the pre- and post-appointment acuity
scores. This supports the effectiveness of provider-assigned patient prioritization triage systems
at accurately identifying acutely ill patients referred to a rheumatology specialty care clinic.
Because timely access to care will continue to be a challenge for providers as the population ages
and imbalances between supply and demand worsen, improving referral processes will be
imperative to facilitate quality patient care outcomes. Our findings suggest that prioritization
triage systems are one mechanism that can positively affect these quality outcomes.

.
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Chapter 5
Capstone Report Conclusion
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Conclusion
Although significant research has been done surrounding the referral process between
primary and specialty care, improvement is needed. In this report, several strategies and tools
have been identified such as improving self-management through educational sessions, blocked
time for new referrals, and collaboratively developed referral guidelines (Davies et al., 2011;
Mariotti et al., 2008; Newman et al., 2004). Pre-appointment management through patient
prioritization systems is a leading effective strategy in identifying acutely ill patients and
reducing wait times to ensure patients are seen in a timely manner (Harrington & Walsh, 2001;
Sathi et al., 2003). Furthermore, PCPs play an important role in reducing wait times by
recognizing patients presenting with early inflammatory arthritis and facilitating prompt
treatment by a rheumatology specialist. Awareness and adherence to guidelines presented in
chapter three will help facilitate the referral by providing recommended information including
laboratory and radiographic studies (Aletaha et al., 2010; Singh et al., 2012). PCPs contribute to
the ongoing care of patients under the supervision of a rheumatology provider by reinforcing
treatment plans including providing life saving vaccinations, monitoring for disease progression
and medication side effects.
The results of this quality improvement project demonstrated that the rheumatology
patient prioritization system strategy evaluated in this study was able to identify acutely ill
patients to ensure they are seen in an appropriate time frame. These findings are consistent with
other studies evaluating specialty provider triage systems (Sathi et al., 2003). This report in
addition to the existing research provides a strong recommendation for implementing a triage
patient prioritization system in clinical areas where there are limited providers and long wait
times. Eliminating delays in care is imperative since early identification and pharmacological
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intervention is not only the standard of care, but can significantly improve morbidity and
mortality (McAlister, Majumdar, Eurich, & Johnson, 2007; Yelin et al., 1998). As the population
ages and the prevalence of arthritic and rheumatic diseases increases, improving the referral
process and decreasing wait times or delays in treatment will become even more necessary. This
project highlights the need for prompt specialty consultation for patients with inflammatory
arthritis, the need for improvement in the referral process, and provides evidence in support of an
effective strategy to address these needs.
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